● TIER 3 — Information onlyGRADE C/D for sport; anecdotalHealing / repair
Actovegin (deproteinized calf-blood hemodialysate)
Origin: Austria/Russia (Takeda, later others); widely used in Russia/E. Europe. Citations verified: yes. 0 human study record(s) in the FitClinicMD studies database.
GOALS · Recovery / injury
FDA status
Not an FDA-approved product
Compounding (503A/503B)
Status varies — see notes
DEA
Not listed as controlled
WADA (sport)
Not specified
Human evidence
No qualifying human studies are catalogued for Actovegin (deproteinized calf-blood hemodialysate) in our database. It is listed here for transparency and reference only.
Reference only. This page summarizes publicly available regulatory and research information about Actovegin (deproteinized calf-blood hemodialysate). It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.